(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclopentylacetic acid, 95.0%, 250mg

5-(4-Nitrophenyl)isoxazole-3-carboxylic acid, 95.0%, 250mg

5-Bromo-2-methylnicotinonitrile, 95.0%, 1g

1-(2,2,2-Trifluoroethyl)piperazine dihydrochloride, 95.0%, 25g

2-aminobenzenesulphonyl fluoride, 95%, 1g

ácido valerénico, con analyt. Documentos, 50 mg, envase de vidrio

(2S,4R)-4-(3-Bromobenzyl)-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid, 95.0%, 1g

(S)-4-Benzyl-2-(6-phenylpyridin-2-yl)-4,5-dihydrooxazole, 97%, 250mg

Ethyl 2-propylthiazole-4-carboxylate, 1g

6,7-Dihydro-5H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-4-amine, 95%, 100mg

Ethyl 2-amino-5-methoxynicotinate, 98%, 100mg

1-(1,3-benzodioxol-5-yl)piperidin-4-one, 95.0%, 10g

5-(4-Chlorobutyl)imidazolidine-2,4-dione, 97.0%, 5g